These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
862 related items for PubMed ID: 31303279
21. Transarterial chemoembolization versus best supportive care for patients with hepatocellular carcinoma with portal vein tumor thrombus:a multicenter study. Xiang X, Lau WY, Wu ZY, Zhao C, Ma YL, Xiang BD, Zhu JY, Zhong JH, Li LQ. Eur J Surg Oncol; 2019 Aug; 45(8):1460-1467. PubMed ID: 31005471 [Abstract] [Full Text] [Related]
25. Survival benefit of hepatic resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis. Zhang XP, Wang K, Li N, Zhong CQ, Wei XB, Cheng YQ, Gao YZ, Wang H, Cheng SQ. BMC Cancer; 2017 Dec 28; 17(1):902. PubMed ID: 29282010 [Abstract] [Full Text] [Related]
26. Transarterial chemoembolization compared with conservative treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus: using a new classification. Niu ZJ, Ma YL, Kang P, Ou SQ, Meng ZB, Li ZK, Qi F, Zhao C. Med Oncol; 2012 Dec 28; 29(4):2992-7. PubMed ID: 22200992 [Abstract] [Full Text] [Related]
27. Propensity Score Matching Analysis of Changes in Alpha-Fetoprotein Levels after Combined Radiotherapy and Transarterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. Jeong Y, Yoon SM, Han S, Shim JH, Kim KM, Lim YS, Lee HC, Kim SY, Park JH, Lee SW, Ahn SD, Choi EK, Kim JH. PLoS One; 2015 Dec 28; 10(8):e0135298. PubMed ID: 26252472 [Abstract] [Full Text] [Related]
28. Transarterial chemoembolization combined with computed tomography-guided 125iodine implantation enhances survival in hepatocellular carcinoma patients with portal vein tumor thrombus. Hu HT, Luo JP, Li HL, Guo CY, Yao QJ, Geng X, Jiang L. Oncotarget; 2017 Apr 25; 8(17):29258-29268. PubMed ID: 28418927 [Abstract] [Full Text] [Related]
29. The safety and efficacy of percutaneous ethanol injection in the treatment of tumor thrombus in advanced hepatocellular carcinoma with portal vein tumor thrombus. Sun B, Zhang W, Chen L, Sun T, Ren Y, Zhu L, Qian K, Zheng C. Abdom Radiol (NY); 2022 Feb 25; 47(2):858-868. PubMed ID: 34820688 [Abstract] [Full Text] [Related]
31. [Curative effect of a comprehensive interventional treatment modality on hepatocellular carcinoma complicated with main branch portal vein tumor thrombosis]. Xu GB, Xiong B, Long QY. Zhonghua Gan Zang Bing Za Zhi; 2013 May 25; 21(5):367-71. PubMed ID: 24025139 [Abstract] [Full Text] [Related]
32. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis. Yamamoto Y, Ikoma H, Morimura R, Shoda K, Konishi H, Murayama Y, Komatsu S, Shiozaki A, Kuriu Y, Kubota T, Nakanishi M, Ichikawa D, Fujiwara H, Okamoto K, Sakakura C, Ochiai T, Otsuji E. World J Gastroenterol; 2015 Jan 07; 21(1):246-53. PubMed ID: 25574098 [Abstract] [Full Text] [Related]
33. TACE-HAIC combined with targeted therapy and immunotherapy versus TACE alone for hepatocellular carcinoma with portal vein tumour thrombus: a propensity score matching study. Yuan Y, He W, Yang Z, Qiu J, Huang Z, Shi Y, Lin Z, Zheng Y, Chen M, Lau WY, Li B, Yuan Y. Int J Surg; 2023 May 01; 109(5):1222-1230. PubMed ID: 37026861 [Abstract] [Full Text] [Related]
34. Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors Plus Immune Checkpoint Inhibitors Versus Tyrosine Kinase Inhibitors Plus Immune Checkpoint Inhibitors in Unresectable Hepatocellular Carcinoma with First- or Lower-Order Portal Vein Tumor Thrombosis. Zhang JX, Cheng Y, Wei J, Fan WL, Liu J, Zhou CG, Liu S, Shi HB, Chu XY, Zheng WL, Zu QQ. Cardiovasc Intervent Radiol; 2024 Jun 01; 47(6):751-761. PubMed ID: 38671322 [Abstract] [Full Text] [Related]
35. Clinical impact of combined transarterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: An external validation study. Yu JI, Park JW, Park HC, Yoon SM, Lim DH, Lee JH, Lee HC, Kim SW, Kim JH. Radiother Oncol; 2016 Feb 01; 118(2):408-15. PubMed ID: 26830695 [Abstract] [Full Text] [Related]
36. Sorafenib With and Without Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma With Main Portal Vein Tumor Thrombosis: A Retrospective Analysis. Zhang Y, Fan W, Wang Y, Lu L, Fu S, Yang J, Huang Y, Yao W, Li J. Oncologist; 2015 Dec 01; 20(12):1417-24. PubMed ID: 26446238 [Abstract] [Full Text] [Related]
37. Prognosis of patients with hepatocellular carcinoma and portal vein tumor thrombus treated with combination of transarterial chemoembolization and palliative thermal ablation. Zhou Q, An Y, Liu T, Liu Z, Li R, Wang C, Zhou F, Liu C, Zhu K. Int J Hyperthermia; 2022 Dec 01; 39(1):97-107. PubMed ID: 34979845 [Abstract] [Full Text] [Related]
38. Assessment of efficacy and safety of the transcatheter arterial chemoembolization with or without apatinib in the treatment of large hepatocellular carcinoma. Liu J, Xie S, Duan X, Chen J, Zhou X, Li Y, Li Z, Han X. Cancer Chemother Pharmacol; 2020 Jan 01; 85(1):69-76. PubMed ID: 31813003 [Abstract] [Full Text] [Related]
39. Portal Vein Irradiation Stent Plus Chemoembolization versus External Radiotherapy Plus Chemoembolization in Hepatocellular Carcinoma with Portal Vein Tumour Thrombus: A Retrospective Study. Tan Z, Lu J, Zhu G, Chen L, Wang Y, Zhang Q, Pan T, Wang J, Guo J, Teng G. Cardiovasc Intervent Radiol; 2021 Sep 01; 44(9):1414-1422. PubMed ID: 34131776 [Abstract] [Full Text] [Related]
40. Efficacy and safety of preoperative chemoembolization for resectable hepatocellular carcinoma with portal vein invasion: a prospective comparative study. Zhang YF, Guo RP, Zou RH, Shen JX, Wei W, Li SH, OuYang HY, Zhu HB, Xu L, Lao XM, Shi M. Eur Radiol; 2016 Jul 01; 26(7):2078-88. PubMed ID: 26396105 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]